CVKD
Cadrenal Therapeutics, Inc.Company with tickers: CVKD
CIK
1937993
CUSIP
127636207
Shares Outstanding
3,078,247
13F Activity (30d)
18 filings
16 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $2,514,378 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $771,508 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-2,514,378 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-2,496,540 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-1.04 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-1.04 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |